Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

To analyse the impact on cycle outcome of LH supplementation in ovarian stimulation controlled with a GnRH antagonist in two ages groups: patients upto 35 years old, and patients aged between 36 and 39 years old.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Treatments: Follicle Stimulating Hormone; Hormones

Criteria

Inclusion Criteria:

• 1st-2nd IVF cycle.

• Age until 39 years old

• BMI: 18-29.9.

• Basal FSH < 12 IU/L

Exclusion Criteria:

• LH:FSH > 2 (PCO)

• Low response background (< 5 oocytes)

• Endometrioma

• Recurrent pregnancy loss

• Any preimplantational genetic diagnosis indication

• Any systemic, metabolic or endocrinological disorder.